QA: Orgenesis Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001460602_2016_Orgenesis_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001460602, Orgenesis Inc

  xvar xval
0 AssetsCurrent 8,206,000
1 IntangibleAssetsNetIncludingGoodwill 26,188,000
2 PropertyPlantAndEquipmentNet 4,296,000
3 remainder_Assets 58,000
4 LiabilitiesCurrent 16,476,000
5 LiabilitiesNoncurrent 7,254,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 3,880,000
8 SellingGeneralAndAdministrativeExpense 4,035,000
9 ResearchAndDevelopmentExpense 1,067,000
10 remainder_Expenses 303,000
11 remainder_Revenues 2,974,000
12 remainder_NetIncome 1,850,000
13 remainder_ComprehensiveNetIncome -1,268,000
  yvar yval
0 Assets 38,748,000
1 Liabilities 23,730,000
2 Expenses 9,285,000
3 Revenues 2,974,000
4 StockholdersEquity 15,018,000
5 NetIncome -4,461,000
6 ComprehensiveNetIncome -5,095,000
7 BaseVar 38,927,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.885
9 EconomicCapitalRatio 2.21

Edgar->Model Mapping

Feature Distribution